🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 22 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
30/05/2002 33,91 34,90 32,60 33,20 -2,44% 6,78% 398.300
29/05/2002 35,60 35,80 34,01 34,03 -5,02% 5,03% 506.900
28/05/2002 35,81 36,00 33,75 35,83 +1,93% 6,28% 464.000
24/05/2002 34,22 35,70 34,13 35,15 +0,23% 4,59% 612.700
23/05/2002 31,60 35,14 31,00 35,07 +11,58% 13,10% 460.800
22/05/2002 32,40 33,06 31,31 31,43 -4,29% 5,40% 272.200
21/05/2002 33,25 34,21 32,15 32,84 -0,51% 6,20% 337.500
20/05/2002 34,75 34,80 33,00 33,01 -5,55% 5,18% 341.100
17/05/2002 34,30 35,24 34,10 34,95 +3,40% 3,32% 251.500
16/05/2002 35,74 35,75 32,98 33,80 -4,38% 7,75% 458.200
15/05/2002 34,73 36,52 33,35 35,35 +1,38% 9,13% 577.500
14/05/2002 31,73 35,50 31,72 34,87 +10,87% 11,91% 791.000
13/05/2002 30,10 32,10 30,01 31,45 +3,69% 6,94% 359.600
10/05/2002 31,61 31,73 29,00 30,33 -4,05% 8,64% 567.400
09/05/2002 32,75 34,45 31,60 31,61 -5,33% 8,70% 449.800
08/05/2002 29,23 33,81 29,23 33,39 +15,14% 15,67% 801.500
07/05/2002 29,76 30,88 28,84 29,00 -2,65% 6,85% 596.400
06/05/2002 33,00 33,00 29,79 29,79 -9,59% 9,73% 447.500
03/05/2002 32,33 33,46 30,50 32,95 +0,98% 9,16% 524.400
02/05/2002 33,86 34,45 32,40 32,63 -2,94% 6,05% 357.800
01/05/2002 33,00 34,30 32,95 33,62 +2,22% 4,09% 455.700
30/04/2002 32,22 33,60 31,54 32,89 +0,89% 6,39% 1.172.900
29/04/2002 35,47 35,50 32,40 32,60 -8,84% 8,74% 470.100
26/04/2002 37,51 38,05 35,46 35,76 -5,52% 6,90% 496.900
25/04/2002 39,70 39,70 36,27 37,85 -4,68% 8,64% 446.000
24/04/2002 40,45 40,67 38,76 39,71 -2,19% 4,72% 241.900
23/04/2002 40,81 41,79 40,44 40,60 -1,34% 3,31% 74.000
22/04/2002 41,99 41,99 40,52 41,15 -3,04% 3,50% 204.400
19/04/2002 42,80 43,88 41,40 42,44 -2,03% 5,79% 250.900
18/04/2002 41,05 43,34 40,58 43,32 +5,45% 6,72% 276.100